< em > Ex vivo < /em > liver resection and auto-transplantation and special systemic therapy in perihilar cholangiocarcinoma treatment
In conclusion, pCCA is still hard to treat due to late diagnosis and extremely complicated surgical options. ELRAT also brings some hope, but it could be performed in very carefully selected patients. Advanced disease requires systemic anticancer treatment, which is supposed to be individualized according to the genetic and molecular features of cancer cells. Targeted therapy in combination with chemo-immunotherapy could be effective in susceptible patients.PMID:38577079 | PMC:PMC10989340 | DOI:10.4240/wjgs.v16.i3.635
Source: Hand Surgery - Category: Surgery Authors: Konstantin Y Tchilikidi Source Type: research
More News: Bile Duct Cancer | Cancer | Cancer & Oncology | Chemotherapy | Cholangiocarcinoma | Gastroenterology | Genetics | Immunotherapy | Liver | Liver Transplant | Palliative | Surgery | Transplants | Urology & Nephrology